Gerresheimer at Pharmapack 2024: Innovative solutions and expert presentations
Broad portfolio for biologics, including cell and gene therapy products Digitally connected Drug Delivery Devices for s…
Broad portfolio for biologics, including cell and gene therapy products Digitally connected Drug Delivery Devices for s…
STRATEGISCHE PARTNERSCHAFT ZUR BESCHLEUNIGUNG VON DEWPOINTS FÜHRENDEN PROGRAMMEN DER ONKOLOGIE-PIPELINE BIS ZUR EINR…
. - Suitable for cryogenic storage - High break resistance - Prevention of delamination Gerresheimer, innovative syste…
Europe's leading provider of AI software for pathology, Mindpeak (Hamburg), has announced groundbreaking work with leadi…
. - Shatter-resistant injection vials maximize patient and production safety - Optional Velocity coating for outstanding…
Gerresheimer presents an extensive portfolio of containment solutions, drug delivery systems and digital therapy suppor…
Eckert & Ziegler (ISIN DE0005659700, TecDAX) today announced they have entered into a comprehensive collaboration agreem…
The field of medical innovation is constantly evolving, and new breakthroughs are being made regularly. It's always a go…
Eckert & Ziegler Radiopharma GmbH, a subsidiary of Eckert & Ziegler Strahlen- und Medizintechnik AG (ISIN DE0005659700,…
Eckert & Ziegler (ISIN DE0005659700, SDAX) has successfully submitted a Type II Drug Master File (DMF) with the U.S. Foo…